Yahoo Finance Cronos Group First Quarter 2023 Earnings: Misses Expectations
Cronos Group (TSE:CRON) First Quarter 2023 Results
Key Financial Results
Revenue: US$20.1m (down 20% from 1Q 2022).
Net loss: US$19.2m (loss narrowed by 41% from 1Q 2022).
US$0.10 loss per share.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Cronos Group Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 19%. Earnings per share (EPS) also missed analyst estimates by 19%.
Looking ahead, revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Pharmaceuticals industry in Canada.
Performance of the Canadian Pharmaceuticals industry.
The company's shares are down 1.2% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of Cronos Group's balance sheet and an in-depth analysis of the company's financial position.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
